Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 0 | 3,489,979 | 0 | 0 | 3,027,994 |
| Cost of Goods | N/A | 654,320 | N/A | N/A | 583,270 |
| Gross Profit | N/A | 2,835,658 | N/A | N/A | 2,444,723 |
| Operating Expenses | 0 | 2,065,870 | 0 | 0 | 2,120,789 |
| Operating Income | N/A | 770,109 | N/A | N/A | 324,205 |
| Interest Expense | 0 | 40,696 | 0 | 0 | 28,768 |
| Other Income | 0 | -105,542 | 0 | 0 | 27,731 |
| Pre-tax Income | 0 | 623,870 | 0 | 0 | 323,168 |
| Income Tax | N/A | 151,759 | N/A | N/A | 82,509 |
| Net Income Continuous | N/A | 472,112 | N/A | N/A | 240,659 |
| Net Income | $N/A | $472,112 | $N/A | $N/A | $240,659 |
| EPS Basic Total Ops | N/A | 0.26 | N/A | N/A | 0.13 |
| EPS Basic Continuous Ops | N/A | 0.26 | N/A | N/A | 0.13 |
| EPS Diluted Total Ops | N/A | 0.26 | N/A | N/A | 0.13 |
| EPS Diluted Continuous Ops | N/A | 0.26 | N/A | N/A | 0.13 |
| EPS Diluted Before Non-Recurring Items | 0.30 | 0.40 | 0.30 | 0.13 | 0.24 |
| EBITDA(a) | $N/A | $1,099,957 | $N/A | $N/A | $645,920 |